Bedel et al., revealed that inhibition or knockdown of STAT3 in the colorectal cancer cell line HT29 leads to stronger activation of NK cells and therefore killing of tumor cells in an NKG2D-dependent manner. This evidence concerns the gene KLRK1 and colorectal cancer.